Prostate cancer heterogeneity: Discovering novel molecular targets for therapy

•Prostate cancer (PCa) shows a broad spectrum of biological and clinical behavior, which represents the epiphenomenon of an extreme genetic heterogeneity.•The AR and PI3K/Akt/mTOR signaling pathways are the two most frequently altered, representing therefore interestingly targets for therapy.•Germli...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Cancer treatment reviews Ročník 54; s. 68 - 73
Hlavní autoři:	Ciccarese, Chiara, Massari, Francesco, Iacovelli, Roberto, Fiorentino, Michelangelo, Montironi, Rodolfo, Di Nunno, Vincenzo, Giunchi, Francesca, Brunelli, Matteo, Tortora, Giampaolo
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Netherlands Elsevier Ltd 01.03.2017
Témata:	Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism BRCA CRPC DNA Repair - drug effects DNA Repair - genetics DRG Hematology, Oncology and Palliative Medicine Heterogeneity Humans Male Molecular Targeted Therapy - methods PARPi Phosphatidylinositol 3-Kinases - metabolism Prostate cancer Prostatic Neoplasms - drug therapy Prostatic Neoplasms - genetics Prostatic Neoplasms - metabolism Proto-Oncogene Proteins c-akt - metabolism PTEN PTEN Phosphohydrolase - genetics Receptors, Androgen - metabolism Signal Transduction - drug effects TOR Serine-Threonine Kinases - metabolism Heterogeneity BRCA DRG PTEN PARPi Prostate cancer CRPC
ISSN:	0305-7372, 1532-1967, 1532-1967
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!